Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study)
Published: 10 February 2022| Version 1 | DOI: 10.17632/8wvxff49g8.1
Contributors:
, , , , , , , , , , , , , , , , , , , , , , , Description
DOI: 10.1002/ccd.29683 Patients with cardiogenic shock and concomitant severe mitral regurgitation have high mortality rates. This study evaluated the procedural safety and efficacy at short and mid-term of edge-to-edge percutaneous mitral valve repair (PMVR) in this setting. We found that edge-to-edge PMVR had an acceptable complication rate and procedural success was a predictor of both 30-day and 6-month survival. We concluded that edge-to-edge PMVR is a safe and effective procedure in patients with severe mitral regurgitation complicating cardiogenic shock and could be considered a bailout option in this setting.
Files
Steps to reproduce
Please refer to the publication details
Institutions
- Universita Vita Salute San RaffaeleLombardia, Milano
- IRCCS Ospedale San RaffaeleLombardy, Milan
Categories
Shock, Mitral Valve Disease, Mitral Valve Surgery, Circulation Support, Percutaneous Valve, Transcatheter Therapy